000			02328 a2200637 4500
005			20250516201737.0
264		0	_c20150207
008			201502s 0 0 eng d
022			_a1932-6203
024	7		_a10.1371/journal.pone.0090224 _2doi
040			_aNLM _beng _cNLM
100	1		_aKomar-Stossel, Chani
245	0	0	_aTL-118 and gemcitabine drug combination display therapeutic efficacy in a MYCN amplified orthotopic neuroblastoma murine model--evaluation by MRI. _h[electronic resource]
260			_bPloS one _c2014
300			_ae90224 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aCimetidine _xadministration & dosage
650	0	4	_aCyclophosphamide _xadministration & dosage
650	0	4	_aDeoxycytidine _xadministration & dosage
650	0	4	_aDiclofenac _xadministration & dosage
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrug Combinations
650	0	4	_aDrug Synergism
650	0	4	_aGene Amplification
650	0	4	_aHumans
650	0	4	_aImmunohistochemistry
650	0	4	_aMagnetic Resonance Imaging _xmethods
650	0	4	_aMale
650	0	4	_aMice, Inbred NOD
650	0	4	_aMice, SCID
650	0	4	_aN-Myc Proto-Oncogene Protein
650	0	4	_aNeovascularization, Pathologic _xdrug therapy
650	0	4	_aNeuroblastoma _xblood supply
650	0	4	_aNuclear Proteins _xgenetics
650	0	4	_aOncogene Proteins _xgenetics
650	0	4	_aPlatelet Endothelial Cell Adhesion Molecule-1 _xmetabolism
650	0	4	_aSulfasalazine _xadministration & dosage
650	0	4	_aTreatment Outcome
650	0	4	_aTretinoin _xadministration & dosage
650	0	4	_aTumor Burden _xdrug effects
650	0	4	_aXenograft Model Antitumor Assays
650	0	4	_aGemcitabine
700	1		_aGross, Eitan
700	1		_aDery, Elia
700	1		_aCorchia, Nathalie
700	1		_aMeir, Karen
700	1		_aFried, Iris
700	1		_aAbramovitch, Rinat
773	0		_tPloS one _gvol. 9 _gno. 3 _gp. e90224
856	4	0	_uhttps://doi.org/10.1371/journal.pone.0090224 _zAvailable from publisher's website
999			_c23617303 _d23617303